U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 11:39:00 GMT 2025
Edited
by admin
on Wed Apr 02 11:39:00 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1|KAPPA
Sequence Origin HUMANIZED RABBIT
Sequence Type COMPLETE
Record UNII
P457A8A6EH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Bocunebart
INN  
Official Name English
LU AG-09222
Preferred Name English
IGHV3-66*01 (81.4%) -(IGHD) -IGHJ1*01 (100%), CDR-IMGT [8.7.6] (26-33.51-57.96-101)) (1-112) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14, 8-G1v29 CH2 A84.4 (CH1 R120>K (209) (113-210), hinge 1-15 (211-225), CH2 N84.4>A (292) (226-33
Common Name English
immunoglobulin G1-kappa, anti-[Homo sapiens ADCYAP1 (adenylate cyclase-activating polypeptide 1, pituitary adenylate cyclase-activating polypeptide, PACAP)], humanized monoclonal antibody
Common Name English
Immunoglobulin G1 [292-alanine], anti-(human pituitary adenylate cyclase-activating peptide) (human-Oryctolagus cuniculus monoclonal Lu AG09222 ?1-chain), disulfide with human-Oryctolagus cuniculus monoclonal Lu AG09222 ?-chain, dimer
Common Name English
LU AG09222
Code English
bocunebart [INN]
Common Name English
Code System Code Type Description
FDA UNII
P457A8A6EH
Created by admin on Wed Apr 02 11:39:00 GMT 2025 , Edited by admin on Wed Apr 02 11:39:00 GMT 2025
PRIMARY
CAS
2984605-64-1
Created by admin on Wed Apr 02 11:39:00 GMT 2025 , Edited by admin on Wed Apr 02 11:39:00 GMT 2025
PRIMARY
INN
13356
Created by admin on Wed Apr 02 11:39:00 GMT 2025 , Edited by admin on Wed Apr 02 11:39:00 GMT 2025
PRIMARY
From To
1_23 1_96
2_23 2_96
2_140 2_196
2_216 4_217
2_257 2_317
1_140 1_196
2_363 2_421
3_24 3_90
3_137 3_197
4_24 4_90
4_137 4_197
1_216 3_217
1_222 2_222
1_225 2_225
1_257 1_317
1_363 1_421
Related Record Type Details
TARGET->LIGAND
Pre-Clinical
IN-VIVO
TARGET->LIGAND
Pre-Clinical
IN-VIVO
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_1] [2_1] N-TERMINUS Q PIDOLIC ACID SZB83O1W42
AMINO ACID REMOVAL [1_443] [2_443] C-TERMINUS K Amount: LYSINE K3Z4F929H6
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL